Humana Inc.
HUM
Positions held
Your positionsHUM isn't in your positions.
Add it to see shares, cost, and P&L here.
Bull / bear case
Site-generated summary from fundamentals, news, and score — not investment advice. As of 2026-10-07.
- Humana Inc. is well-positioned in the healthcare plans industry, benefiting from a growing demand for healthcare services and a strong competitive strategy focused on member engagement and technology integration.
- Revenue increased by 3% compared to the prior quarter, reaching $40.9 billion.
- The company has a strong buy recommendation with a score of 47.00, indicating positive market sentiment.
- The healthcare plans industry faces regulatory challenges that could impact profitability and operational flexibility for companies like Humana.
- In 2025-Q4, Humana reported a net income loss of $796 million, highlighting potential financial instability.
- The trailing P/E ratio of 38.21 suggests that the stock may be overvalued compared to its earnings growth.
Fundamentals
| Market cap | $46.49B | Enterprise value | $37.42B | Trailing P/E | 36.59 | Forward P/E | 23.22 |
| PEG | 1.33 | Price / book | 2.42 | Beta | 0.74 | Dividend yield | 0.91% |
| Revenue growth | 26.2% | Earnings growth | 27.1% | Gross margin | 13.7% | Operating margin | 3.5% |
| Profit margin | 0.9% | ROE | 6.9% | ROA | 3.9% | Debt / equity | 0.76 |
| Current ratio | 1.74 | Free cash flow | $1.94B | Analyst recommendation | buy | Mean target | $430.70 |
| 52w high | $428.88 | 52w low | $163.11 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $40.9B | $39.6B | $32.5B | $32.6B | $32.4B | — |
| Op margin | — | — | — | — | — | — |
| Net income | $694M | $1.2B | -$796M | $195M | $545M | — |
| Gross margin | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — |
| Operating income | — | — | — | — | — | — |
- Revenue +3% vs prior quarter ($40.9B vs $39.6B).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $129.7B | $117.8B | $106.4B | $92.9B |
| Op margin | — | — | — | — |
| Net income | $1.2B | $1.2B | $2.5B | $2.8B |
| Gross margin | — | — | — | — |
| Gross profit | — | — | — | — |
| Operating income | — | — | — | — |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-10-09 · Sector Update: Healthcare Stocks Gain Friday Afternoon
2026-10-09 · Humana Leads Managed Care Peers in 2027 Medicare Advantage Star Ratings, Deutsche Bank Says
2026-10-09 · Stock Market Midday, Oct. 9: Stocks Edge Higher, Humana jumps 13%
2026-10-09 · SpaceX, AT&T, Crown Castle, Delta, Humana, and More Stocks That Explain Today’s Market
2026-10-09 · Top Midday Gainers
2026-10-09 · CVS Stock Dips After Drop in Medicare Advantage Plan Ratings
2026-10-09 · UnitedHealth vs. Humana: Which Healthcare Giant Has the Edge?
2026-10-09 · Humana Says 95% of Its Medicare Advantage Members in Plans With At Least 4 Stars for 2027
2026-10-09 · Seniors Face an 18% Drop in Highly Rated Medicare Advantage Plans — But Quality Might Not Be the Cause
2026-10-09 · Humana Stock Jumps After Insurer Gets High Medicare Ratings
Price (daily)
Full chart · RSI · MACD · patternsOn Trade and Ticker
- 2026-10-09 · Morning BriefFutures Rise as AI Stocks Rebound on OpenAI; Delta Cuts Outlook, Telecoms Slide
- 2026-10-09 · Midday UpdateStocks Rise as Verizon Has Worst Day Since 2002; Oracle Up, Chips Fade
- 2026-10-09 · Closing WrapVerizon and T-Mobile Sink on SpaceX, Humana's Star Ratings, Delta, Palantir